Azul's Restructuring Misses Key Details And May Come With Massive Dilution
Azul has been on a (downward) rollercoaster for the past few months. Read why I maintain my Hold rating on AZUL stock.
BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of ...